BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18474044)

  • 1. The evolution of tools for protein phosphorylation site analysis: from discovery to clinical application.
    Bonilla L; Means G; Lee K; Patterson S
    Biotechniques; 2008 Apr; 44(5):671-9. PubMed ID: 18474044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current trends in computational inference from mass spectrometry-based proteomics.
    Webb-Robertson BJ; Cannon WR
    Brief Bioinform; 2007 Sep; 8(5):304-17. PubMed ID: 17584764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactive proteomics: what lies ahead?
    Suter B; Kittanakom S; Stagljar I
    Biotechniques; 2008 Apr; 44(5):681-91. PubMed ID: 18474045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of current applications of mass spectrometry for neuroproteomics in epilepsy.
    Liu X; Wen F; Yang J; Chen L; Wei YQ
    Mass Spectrom Rev; 2010; 29(2):197-246. PubMed ID: 19598206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometric tools for systematic analysis of protein phosphorylation.
    St-Denis N; Gingras AC
    Prog Mol Biol Transl Sci; 2012; 106():3-32. PubMed ID: 22340712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and cellular approaches for the detection of protein-protein interactions: latest techniques and current limitations.
    Lalonde S; Ehrhardt DW; Loqué D; Chen J; Rhee SY; Frommer WB
    Plant J; 2008 Feb; 53(4):610-35. PubMed ID: 18269572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The social network of a cell: recent advances in interactome mapping.
    Charbonnier S; Gallego O; Gavin AC
    Biotechnol Annu Rev; 2008; 14():1-28. PubMed ID: 18606358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced technologies for studies on protein interactomes.
    Guan H; Kiss-Toth E
    Adv Biochem Eng Biotechnol; 2008; 110():1-24. PubMed ID: 18219467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometry: m/z 1983-2008.
    Zhou M; Veenstra T
    Biotechniques; 2008 Apr; 44(5):667-8, 670. PubMed ID: 18474043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards functional phosphoproteomics by mapping differential phosphorylation events in signaling networks.
    de la Fuente van Bentem S; Mentzen WI; de la Fuente A; Hirt H
    Proteomics; 2008 Nov; 8(21):4453-65. PubMed ID: 18972525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and strategies for targeted phosphorylation site identification and quantification using mass spectrometry analysis.
    Blackburn K; Goshe MB
    Brief Funct Genomic Proteomic; 2009 Mar; 8(2):90-103. PubMed ID: 19109306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human protein-protein interaction networks and the value for drug discovery.
    Ruffner H; Bauer A; Bouwmeester T
    Drug Discov Today; 2007 Sep; 12(17-18):709-16. PubMed ID: 17826683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant phosphoproteomics: an update.
    Kersten B; Agrawal GK; Durek P; Neigenfind J; Schulze W; Walther D; Rakwal R
    Proteomics; 2009 Feb; 9(4):964-88. PubMed ID: 19212952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of protein phosphorylation using mass spectrometry.
    Wu HY; Liao PC
    Chang Gung Med J; 2008; 31(3):217-27. PubMed ID: 18782944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting protein-protein interactions using designed molecules.
    Zhao L; Chmielewski J
    Curr Opin Struct Biol; 2005 Feb; 15(1):31-4. PubMed ID: 15718130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific modulation of protein kinase activity via small peptides.
    Costa-Junior HM; Suetsugu MJ; Krieger JE; Schechtman D
    Regul Pept; 2009 Feb; 153(1-3):11-8. PubMed ID: 19135095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of cell signaling and drug action via mass spectrometry-based systems level phosphoproteomics.
    Tedford NC; Hall AB; Graham JR; Murphy CE; Gordon NF; Radding JA
    Proteomics; 2009 Mar; 9(6):1469-87. PubMed ID: 19294625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry in systems biology: an overview.
    Feng X; Liu X; Luo Q; Liu BF
    Mass Spectrom Rev; 2008; 27(6):635-60. PubMed ID: 18636545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry analysis of new chemical entities for pharmaceutical discovery.
    Fang AS; Miao X; Tidswell PW; Towle MH; Goetzinger WK; Kyranos JN
    Mass Spectrom Rev; 2008; 27(1):20-34. PubMed ID: 18033735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of LC/MS and related techniques to high-throughput drug discovery.
    Espada A; Molina-Martin M; Dage J; Kuo MS
    Drug Discov Today; 2008 May; 13(9-10):417-23. PubMed ID: 18468559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.